The acetylation process determines increased levels of EGR1 protein, which can strongly stimulate the expression of genes involved in cell growth and survival, playing a crucial role in prostate and kidney cancers (Yu et al., 2004; Gitenay and Baron, 2009). This evidence concerns the gene EGR1 and kidney cancer.